← back to search

Thomas Ransom

Dalhousie University · CA
Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research interests include Diabetes Treatment and Management, Diabetes Management and Research, Diabetes, Cardiovascular Risks, and Lipoproteins, and Lipoproteins and Cardiovascular Health.
h-index
22
citations
3,672
works
56
NIH funding
primary concept
Medicine
email

Recent publications

Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes
JAMA Cardiology 2026cited by 0position: middledoi
Closed-Loop Insulin Delivery in Type 1 Diabetes in Pregnancy
JAMA 2025cited by 7position: middledoi
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
The Lancet Diabetes & Endocrinology 2021cited by 176position: middledoi
Continuous Glucose Monitoring Time-in-Range and HbA <sub>1c</sub> Targets in Pregnant Women with Type 1 Diabetes
Diabetes Technology & Therapeutics 2021cited by 48position: middledoi
Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial
The Lancet Diabetes & Endocrinology 2020cited by 228position: middledoi
Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes
Diabetes Care 2020cited by 81position: middledoi
Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial
Diabetes Care 2018cited by 124position: middledoi
Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial
The Lancet 2017cited by 766position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

No co-authors indexed yet.